{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:22:34Z","timestamp":1795072954779,"version":"4.10.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Post-stroke delirium affects between 24% and 43% of patients, and negatively impacts patient outcomes. Recently, research attention has been on preventive interventions for delirium, with melatonin receptor agonists and orexin receptor antagonists reported to be effective in preventing delirium in intensive care unit patients. However, the efficacy of these agents in preventing post-stroke delirium remain unclear. This study examined the efficacy of ramelteon, suvorexant, and lemborexant in preventing post-stroke delirium symptoms in patients with stroke.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective survey of medical records was conducted for patients with stroke aged\u2009&gt;\u200975 years at Kyoto University Hospital from October 2021 to March 2023. Patients who received ramelteon, suvorexant, or lemborexant on admission and the following day were classified into the consecutive administration group, whereas those who did not were classified into the non-consecutive administration group. The primary outcome was an increase in the number of positive items in the delirium screening tool over 7 days.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 104 patients, 33 and 71 were in the consecutive and non-consecutive administration groups, respectively. Fewer patients in the consecutive administration group had an increase in the number of positive items than in the other group (6% vs. 21%). Patients in the consecutive administration group significantly less often had an increase in the number of positive items in the delirium screening tool (<jats:italic>P<\/jats:italic>\u2009=\u20090.05; hazard ratio, 0.27; 95% confidence interval, 0.10\u20130.75).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study revealed that early administration of a melatonin receptor agonist or orexin receptor antagonists may effectively prevent post-stroke delirium in older patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40780-024-00397-z","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T10:08:40Z","timestamp":1731924520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy of a melatonin receptor agonist and orexin receptor antagonists in preventing delirium symptoms in the olderly patients with stroke: a retrospective study"],"prefix":"10.1186","volume":"10","author":[{"given":"Yukiko","family":"Miyoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7033-5357","authenticated-orcid":false,"given":"Yuki","family":"Shigetsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Hira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takakuni","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Kitada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiko","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Katsube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Imayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsaku","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"397_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD 2019 Stroke Collaborators","year":"2021","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet Neurol. 2021;20:795\u2013820.","journal-title":"Lancet Neurol"},{"key":"397_CR2","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1161\/STROKEAHA.117.017952","volume":"49","author":"RI Lindley","year":"2018","unstructured":"Lindley RI. Stroke prevention in the very elderly. Stroke. 2018;49:796\u2013802.","journal-title":"Stroke"},{"key":"397_CR3","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147:e93\u2013621.","journal-title":"Circulation"},{"key":"397_CR4","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","volume":"31","author":"ZM Chen","year":"2000","unstructured":"Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000;31:1240\u20139.","journal-title":"Stroke"},{"key":"397_CR5","doi-asserted-by":"crossref","unstructured":"Sandercock P, Gubitz G, Foley P, Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2003;2:CD000029.","DOI":"10.1002\/14651858.CD000029"},{"key":"397_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71\u201386.","journal-title":"BMJ"},{"key":"397_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1161\/STROKEAHA.107.492363","volume":"39","author":"J Bernhardt","year":"2008","unstructured":"Bernhardt J, Dewey H, Thrift A, Collier J, Donnan G. A very early rehabilitation trial for stroke (AVERT): phase II safety and feasibility. Stroke. 2008;39:390\u20136.","journal-title":"Stroke"},{"key":"397_CR8","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/jama.1987.03400130103041","volume":"258","author":"ZJ Lipowski","year":"1987","unstructured":"Lipowski ZJ. Delirium (acute confusional states). JAMA. 1987;258:1789\u201392.","journal-title":"JAMA"},{"key":"397_CR9","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/s00415-011-6383-4","volume":"259","author":"G Carin-Levy","year":"2012","unstructured":"Carin-Levy G, Mead GE, Nicol K, Rush R, van Wijck F. Delirium in acute stroke: screening tools, incidence rates and predictors: a systematic review. J Neurol. 2012;259:1590\u20139.","journal-title":"J Neurol"},{"key":"397_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/01.STR.30.4.773","volume":"30","author":"H H\u00e9non","year":"1999","unstructured":"H\u00e9non H, Lebert F, Durieu I, Godefroy O, Lucas C, Pasquier F, et al. Confusional state in stroke: relation to preexisting dementia, patient characteristics, and outcome. Stroke. 1999;30:773\u20139.","journal-title":"Stroke"},{"key":"397_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3109\/02699052.2012.660510","volume":"26","author":"M Kostalova","year":"2012","unstructured":"Kostalova M, Bednarik J, Mitasova A, Du\u0161ek L, Michalcakova R, Kerkovsky M, et al. Towards a predictive model for post-stroke delirium. Brain Inj. 2012;26:962\u201371.","journal-title":"Brain Inj"},{"key":"397_CR12","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/gps.2254","volume":"24","author":"J Mc Manus","year":"2009","unstructured":"Mc Manus J, Pathansali R, Hassan H, Ouldred E, Cooper D, Stewart R, et al. The evaluation of delirium post-stroke. Int J Geriatr Psychiatry. 2009;24:1251\u20136.","journal-title":"Int J Geriatr Psychiatry"},{"key":"397_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1447-0594.2012.00871.x","volume":"13","author":"DK Miu","year":"2013","unstructured":"Miu DK, Yeung JC. Incidence of post-stroke delirium and 1-year outcome. Geriatr Gerontol Int. 2013;13:123\u20139.","journal-title":"Geriatr Gerontol Int"},{"key":"397_CR14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/j.1532-5415.2006.00806.x","volume":"54","author":"AZ Sheng","year":"2006","unstructured":"Sheng AZ, Shen Q, Cordato D, e Zhang YY, Yin Chan DK. Delirium within three days of stroke in a cohort of elderly patients. J Am Geriatr Soc. 2006;54:1192\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"397_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jama.2010.1013","volume":"304","author":"J Witlox","year":"2010","unstructured":"Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304:443\u201351.","journal-title":"JAMA"},{"key":"397_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12883-018-1198-x","volume":"18","author":"P Thingstad","year":"2018","unstructured":"Thingstad P, Askim T, Beyer MK, Br\u00e5then G, Ellekj\u00e6r H, Ihle-Hansen H, et al. The Norwegian cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort study. BMC Neurol. 2018;18:193.","journal-title":"BMC Neurol"},{"key":"397_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapsychiatry.2013.3320","volume":"71","author":"K Hatta","year":"2014","unstructured":"Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, et al. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry. 2014;71:397\u2013403.","journal-title":"JAMA Psychiatry"},{"key":"397_CR18","doi-asserted-by":"publisher","first-page":"e970","DOI":"10.4088\/JCP.16m11194","volume":"78","author":"K Hatta","year":"2017","unstructured":"Hatta K, Kishi Y, Wada K, Takeuchi T, Ito S, Kurata A, et al. Preventive effects of suvorexant on delirium: a randomized placebo-controlled trial. J Clin Psychiatry. 2017;78:e970\u20139.","journal-title":"J Clin Psychiatry"},{"key":"397_CR19","doi-asserted-by":"publisher","first-page":"22m14471","DOI":"10.4088\/JCP.22m14471","volume":"84","author":"A Matsuoka","year":"2022","unstructured":"Matsuoka A, Tobita S, Sogawa R, Shinada K, Murakawa-Hirachi T, Shimanoe C, et al. Evaluation of suvorexant and lemborexant for the prevention of delirium in adult critically ill patients at an advanced critical care center: a single-center, retrospective, observational study. J Clin Psychiatry. 2022;84:22m14471.","journal-title":"J Clin Psychiatry"},{"key":"397_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-2005-867073","volume":"25","author":"CL Bassetti","year":"2005","unstructured":"Bassetti CL. Sleep and stroke. Semin Neurol. 2005;25:19\u201332.","journal-title":"Semin Neurol"},{"key":"397_CR21","first-page":"150","volume":"15","author":"I Machida","year":"2003","unstructured":"Machida I, Aoki T, Kohduki K, Kishi Y, Hoaka T. Development of delirium screening tool. Jpn J Gen Hosp Psychiatry. 2003;15:150\u20135. [in Japanese].","journal-title":"Jpn J Gen Hosp Psychiatry"},{"key":"397_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/ggi.14477","volume":"22","author":"Y Hashimoto","year":"2022","unstructured":"Hashimoto Y, Kano O, Ebihara S. Noise pareidolia test for predicting delirium in hospitalized older patients with cognitive decline. Geriatr Gerontol Int. 2022;22:883\u20138.","journal-title":"Geriatr Gerontol Int"},{"key":"397_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0165-1781(88)90037-6","volume":"23","author":"PT Trzepacz","year":"1988","unstructured":"Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 1988;23:89\u201397.","journal-title":"Psychiatry Res"},{"key":"397_CR24","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","volume":"70","author":"European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice guidelines: drug-induced liver injury. J Hepatol. 2019;70:1222\u201361.","journal-title":"J Hepatol"},{"key":"397_CR25","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179\u201384.","journal-title":"Nephron Clin Pract"},{"key":"397_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/pgmj.2008.072025","volume":"85","author":"S Saxena","year":"2009","unstructured":"Saxena S, Lawley D. Delirium in the elderly: a clinical review. Postgrad Med J. 2009;85:405\u201313.","journal-title":"Postgrad Med J"},{"key":"397_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.1992.03480060073033","volume":"267","author":"JD Schor","year":"1992","unstructured":"Schor JD, Levkoff SE, Lipsitz LA, Reilly CH, Cleary PD, Rowe JW, et al. Risk factors for delirium in hospitalized elderly. JAMA. 1992;267:827\u201331.","journal-title":"JAMA"},{"issue":"12","key":"397_CR28","first-page":"1537","volume":"70","author":"AP Spira","year":"2013","unstructured":"Spira AP, Gamaldo AA, An Y, Wu MN, Simonsick EM, Bilgel M, et al. Self-reported sleep and \u03b2-amyloid deposition in community-dwelling older adults. JAMA Neurol. 2013;70(12):1537\u201343.","journal-title":"JAMA Neurol"},{"key":"397_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/jamapsychiatry.2018.4365","volume":"76","author":"YC Wu","year":"2019","unstructured":"Wu YC, Tseng PT, Tu YK, Hsu CY, Liang CS, Yeh TC, et al. Association of delirium response and safety of pharmacological interventions for the management and prevention of delirium: a network meta-analysis. JAMA Psychiatry. 2019;76:526\u201335.","journal-title":"JAMA Psychiatry"},{"key":"397_CR30","doi-asserted-by":"publisher","first-page":"19m12865","DOI":"10.4088\/JCP.19m12865","volume":"81","author":"K Hatta","year":"2019","unstructured":"Hatta K, Kishi Y, Wada K, Takeuchi T, Hashimoto N, Suda K, et al. Real-world effectiveness of ramelteon and suvorexant for delirium prevention in 948 patients with delirium risk factors. J Clin Psychiatry. 2019;81:19m12865.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"397_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bpa.2012.08.005","volume":"26","author":"PL Watson","year":"2012","unstructured":"Watson PL, Ceriana P, Fanfulla F. Delirium: is sleep important? Best Pract Res Clin Anaesthesiol. 2012;26(3):355\u201366.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"4","key":"397_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4037\/ajcc2021771","volume":"30","author":"CK Chan","year":"2021","unstructured":"Chan CK, Song Y, Greene R, Lindroth H, Khan S, Rios G, et al. Meta-analysis of ICU delirium biomarkers and their alignment with the NIA-AA Research Framework. Am J Crit Care. 2021;30(4):312\u20139.","journal-title":"Am J Crit Care"},{"key":"397_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2021.01.034","volume":"93","author":"JH Cho","year":"2021","unstructured":"Cho JH, Bhutani S, Kim CH, Irwin MR. Anti-inflammatory effects of melatonin: a systematic review and meta-analysis of clinical trials. Brain Behav Immun. 2021;93:245\u201353.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"397_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","volume":"13","author":"MJ Sateia","year":"2017","unstructured":"Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307\u201349.","journal-title":"J Clin Sleep Med"},{"key":"397_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0009-9236(99)90084-X","volume":"65","author":"S Albrecht","year":"1999","unstructured":"Albrecht S, Ihmsen H, Hering W, Geisslinger G, Dingemanse J, Schwilden H, et al. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther. 1999;65:630\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"397_CR36","doi-asserted-by":"publisher","first-page":"e0238723","DOI":"10.1371\/journal.pone.0238723","volume":"15","author":"Y Ishibashi","year":"2020","unstructured":"Ishibashi Y, Nishitani R, Shimura A, Takeuchi A, Touko M, Kato T, et al. Non-GABA sleep medications, suvorexant as risk factors for falls: case-control and case-crossover study. PLoS ONE. 2020;15(9):e0238723.","journal-title":"PLoS ONE"},{"key":"397_CR37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44:870\u2013947.","journal-title":"Stroke"},{"issue":"1","key":"397_CR38","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1097\/JCN.0000000000000356","volume":"32","author":"KL Rice","year":"2017","unstructured":"Rice KL, Bennett MJ, Berger L, Jennings B, Eckhardt L, Fabr\u00e9-LaCoste N, et al. A pilot randomized controlled trial of the feasibility of a Multicomponent Delirium Prevention intervention Versus Usual Care in Acute Stroke. J Cardiovasc Nurs 2. 2017;32(1):E1\u201310.","journal-title":"J Cardiovasc Nurs 2"},{"key":"397_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1176\/jnp.13.2.229","volume":"13","author":"PT Trzepacz","year":"2001","unstructured":"Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the Delirium Rating Scale and the cognitive test for Delirium. J Neuropsychiatry Clin Neurosci. 2001;13:229\u201342.","journal-title":"J Neuropsychiatry Clin Neurosci"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-024-00397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-024-00397-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-024-00397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T03:07:31Z","timestamp":1731985651000},"score":1,"resource":{"primary":{"URL":"https:\/\/jphcs.biomedcentral.com\/articles\/10.1186\/s40780-024-00397-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1186\/s40780-024-00397-z","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Ethical Guidelines for Life Science and Medical Reseach Involving Human Subjects, and was reviewed by the Ethics Committee of the Kyoto University Graduate School and Faculty of Medicine (approval number, R0545-2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}